At Endeavour Vision we are taking this global opportunity seriously. We are a UNPRI (United Nations Principle for Responsible Investment) signatory, reporting annually on our progress at every stage of the investment process towards responsible investing. In 2021, we published the first impact analysis of our EMG II fund that looks at the clinical, healthcare and societal impact of portfolio companies and their technologies.
We believe that medical innovation can improve the standard of care for millions of people, positively impact patients’ wellbeing and bring efficiency and innovation to global health systems. As the world’s population ages and healthcare budgets strain to keep pace with mounting costs, healthcare innovations can support the achievement of the UN Sustainable Development Goals (SDGs), including SDG3 – Good health and well-being, SDG8 – Decent work and economic growth, SDG9 – Industry, innovation and infrastructure and SDG5 – achieving gender equality and empowering all women and girls.